12:00 AM
Jan 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Hisamitsu, Yutoku Pharmaceutical deal

Hisamitsu acquired a 15% stake in Yutoku Pharmaceutical through the purchase of 18,000 shares at an undisclosed price. Hisamitsu said the stake represents a...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >